These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1358775)

  • 1. Pharmacokinetics of glafenine and glafenic acid in patients with cirrhosis, compared to healthy volunteers.
    Vermerie N; Kusielewicz D; Tod M; Nicolas P; Perret G; Fauvelle F; Petitjean O
    Fundam Clin Pharmacol; 1992; 6(4-5):197-203. PubMed ID: 1358775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective high-performance liquid chromatographic determination of glafenine in plasma: pharmacokinetic application.
    Ennachachibi A; Nicolas P; Fauvelle F; Perret G; Petitjean O
    J Chromatogr; 1988 Jun; 427(2):307-14. PubMed ID: 2900842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of molsidomine and its active metabolite, linsidomine, in patients with liver cirrhosis.
    Spreux-Varoquaux O; Doll J; Dutot C; Grandjean N; Cordonnier P; Pays M; Andrieu J; Advenier C
    Br J Clin Pharmacol; 1991 Sep; 32(3):399-401. PubMed ID: 1777378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous and oral pentoxifylline in healthy volunteers and in cirrhotic patients.
    Rames A; Poirier JM; LeCoz F; Midavaine M; Lecocq B; Grange JD; Poupon R; Cheymol G; Jaillon P
    Clin Pharmacol Ther; 1990 Mar; 47(3):354-9. PubMed ID: 2178853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of fluvoxamine maleate in patients with liver cirrhosis after single-dose oral administration.
    van Harten J; Duchier J; Devissaguet JP; van Bemmel P; de Vries MH; Raghoebar M
    Clin Pharmacokinet; 1993 Feb; 24(2):177-82. PubMed ID: 8453824
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Renal pelvis stones made of glafenic acid in two patients under prolonged treatment with analgesics (author's transl)].
    Réveillaud RJ; Daudon M; Protat MF; Rymer M; Amar E; Pottier J
    Nephrologie; 1980; 1(1):3-8. PubMed ID: 6117808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical pharmacokinetics of mizolastine.
    Lebrun-Vignes B; Diquet B; Chosidow O
    Clin Pharmacokinet; 2001; 40(7):501-7. PubMed ID: 11510627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of metoclopramide in patients with liver cirrhosis.
    Magueur E; Hagege H; Attali P; Singlas E; Etienne JP; Taburet AM
    Br J Clin Pharmacol; 1991 Feb; 31(2):185-7. PubMed ID: 2049236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
    Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
    Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral pharmacokinetics and ascitic fluid penetration of pefloxacin in cirrhosis.
    Cardey J; Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Fourtillan JP; Beauchant M
    Eur J Clin Pharmacol; 1987; 33(5):469-72. PubMed ID: 3480805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformations of glafenine in the rat and in man.
    Pottier J; Busigny M; Raynaud JP
    Eur J Drug Metab Pharmacokinet; 1979; 4(2):109-15. PubMed ID: 39763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of a single oral dose of clobazam in patients with liver disease.
    Monjanel-Mouterde S; Antoni M; Bun H; Botta-Frindlund D; Gauthier A; Durand A; Cano JP
    Pharmacol Toxicol; 1994 Jun; 74(6):345-50. PubMed ID: 7937568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver blood flow, antipyrine clearance, and antipyrine metabolite formation clearance in patients with chronic active hepatitis and alcoholic cirrhosis.
    Bauer LA; O'Sullivan T; Reiss WG; Horn JR; Opheim K; Strandness DE; Carithers RL
    Br J Clin Pharmacol; 1994 Apr; 37(4):375-81. PubMed ID: 8018459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of ibuprofen in patients with liver cirrhosis. Stereochemical considerations.
    Li G; Treiber G; Maier K; Walker S; Klotz U
    Clin Pharmacokinet; 1993 Aug; 25(2):154-63. PubMed ID: 8403739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic disposition of isoxicam in hepatic cirrhosis.
    Esquivel M; Ogilvie RI; East DS; Shaw DH; Heathcote J
    Clin Invest Med; 1987 Sep; 10(5):363-7. PubMed ID: 3677504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral pharmacokinetics and ascitic fluid penetration of ofloxacin in cirrhosis.
    Silvain C; Bouquet S; Breux JP; Becq-Giraudon B; Beauchant M
    Eur J Clin Pharmacol; 1989; 37(3):261-5. PubMed ID: 2612541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The comparative pharmacokinetics of modified-release and immediate-release paracetamol in a simulated overdose model.
    Chiew A; Day P; Salonikas C; Naidoo D; Graudins A; Thomas R
    Emerg Med Australas; 2010 Dec; 22(6):548-55. PubMed ID: 21143403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and protein binding of cefpiramide in patients with alcoholic cirrhosis.
    Demotes-Mainard F; Vinçon G; Amouretti M; Dumas F; Necciari J; Kieffer G; Begaud B
    Clin Pharmacol Ther; 1991 Mar; 49(3):263-9. PubMed ID: 2007321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single dose pharmacokinetics of manidipine in hepatic impaired patients and healthy controls.
    Deroubaix X; Lins RL; Lens S; Allemon A; Jeanbaptiste B; Poli G; Acerbi D; Stockis A; Ventura P
    Int J Clin Pharmacol Ther; 1998 Jul; 36(7):386-91. PubMed ID: 9707354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.